$ACET
Adicet Bio, Inc.

2019 Q1 Form 10-K Financial Statement

#000156459019008262 Filed on March 18, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.840M $8.640M $730.0K
YoY Change 35.89% 323.53%
% of Gross Profit
Research & Development $8.852M $14.72M $6.790M
YoY Change 9.2% -12.6%
% of Gross Profit
Depreciation & Amortization $30.00K $80.00K $10.00K
YoY Change 233.33% 1500.0%
% of Gross Profit
Operating Expenses $11.69M $23.15M $7.520M
YoY Change 14.62% 22.58%
Operating Profit -$11.69M -$39.71M -$7.523M
YoY Change 14.62% 110.28%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $631.0K $2.120M -$15.53M
YoY Change 85.04% -114.23%
Pretax Income -$11.06M -$9.888M -$23.05M
YoY Change 12.18% -70.73%
Income Tax $9.000K -$589.0K $0.00
% Of Pretax Income
Net Earnings -$4.131M -$9.299M -$23.05M
YoY Change -58.1% -72.47%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.674M -$9.950M -$5.748M
COMMON SHARES
Basic Shares Outstanding 28.06M 2.050M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $143.1M $108.0M $53.30M
YoY Change 5.45% 102.63%
Cash & Equivalents $7.181M $7.000M $53.35M
Short-Term Investments $135.9M $101.0M
Other Short-Term Assets $1.600M $1.500M $84.00K
YoY Change 938.96% -16.67%
Inventory
Prepaid Expenses $792.0K
Receivables
Other Receivables
Total Short-Term Assets $144.7M $109.5M $55.15M
YoY Change 5.74% 98.37%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $300.0K $39.00K
YoY Change -5.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change 0.0%
Total Long-Term Assets $400.0K $400.0K $39.00K
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $144.7M $109.5M $55.15M
Total Long-Term Assets $400.0K $400.0K $39.00K
Total Assets $145.1M $109.9M $55.19M
YoY Change 5.72% 99.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.400M $3.000M $1.515M
YoY Change 129.73% 100.0%
Accrued Expenses $1.200M $2.700M $3.987M
YoY Change -75.28% -32.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.600M $5.700M $5.502M
YoY Change -32.69% 3.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.600M $5.700M $5.502M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.600M $5.700M $5.502M
YoY Change -32.96% 3.64%
SHAREHOLDERS EQUITY
Retained Earnings -$33.78M
YoY Change
Common Stock $222.9M $1.000K
YoY Change 7429300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $140.5M $104.2M -$26.95M
YoY Change
Total Liabilities & Shareholders Equity $145.1M $109.9M $55.19M
YoY Change 5.71% 99.09%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$4.131M -$9.299M -$23.05M
YoY Change -58.1% -72.47%
Depreciation, Depletion And Amortization $30.00K $80.00K $10.00K
YoY Change 233.33% 1500.0%
Cash From Operating Activities -$12.05M -$18.18M -$4.990M
YoY Change 64.96% 65.5%
INVESTING ACTIVITIES
Capital Expenditures $24.00K $876.0K $0.00
YoY Change -91.37% 1890.91%
Acquisitions
YoY Change
Other Investing Activities -$34.60M -$100.4M
YoY Change
Cash From Investing Activities -$34.63M -$16.06M $0.00
YoY Change 12356.12% 36395.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 46.82M 11.05M 54.38M
YoY Change -47.95% -82.84%
NET CHANGE
Cash From Operating Activities -12.05M -18.18M -4.990M
Cash From Investing Activities -34.63M -16.06M 0.000
Cash From Financing Activities 46.82M 11.05M 54.38M
Net Change In Cash 139.0K -23.19M 49.39M
YoY Change -99.83% -143.47%
FREE CASH FLOW
Cash From Operating Activities -$12.05M -$18.18M -$4.990M
Capital Expenditures $24.00K $876.0K $0.00
Free Cash Flow -$12.07M -$19.06M -$4.990M
YoY Change 59.23% 72.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2727000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3987000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5716000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5502000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19000
CY2018Q4 us-gaap Liabilities
Liabilities
5735000
CY2017Q4 us-gaap Liabilities
Liabilities
5502000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
132400000
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28055344
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7042000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53349000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100986000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1491000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
792000
CY2017Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
929000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
84000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
109534000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
55154000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
84000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39000
CY2018Q4 us-gaap Assets
Assets
109939000
CY2017Q4 us-gaap Assets
Assets
55193000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2989000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1515000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
175635000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1849000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71393000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33779000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
us-gaap Operating Expenses
OperatingExpenses
1000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-18882000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-41000
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37655000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
0
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33778000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26439216
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
104204000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-31929000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
109939000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55193000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
32000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28055344
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5659089
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28055344
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5659089
CY2018Q4 torc Common Stock Shares Vested
CommonStockSharesVested
28054344
CY2017Q4 torc Common Stock Shares Vested
CommonStockSharesVested
4562640
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31065000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16839000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8640000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2043000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1000
CY2018 us-gaap Operating Expenses
OperatingExpenses
39705000
CY2017 us-gaap Operating Expenses
OperatingExpenses
18882000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-39705000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14896000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2017 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
-1379000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
470000
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
81620000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
89370000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
865000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1928000
CY2018 us-gaap Profit Loss
ProfitLoss
-37614000
CY2017 us-gaap Profit Loss
ProfitLoss
-33778000
us-gaap Profit Loss
ProfitLoss
-1000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
673000
CY2017Q4 torc Deferred Tax Assets Capitalized License
DeferredTaxAssetsCapitalizedLicense
896000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2793000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
470000
CY2017 torc Change In Fair Value Of Tranche Liability
ChangeInFairValueOfTrancheLiability
14896000
CY2017 torc Expense Related To Acquisition Of Intellectual Property
ExpenseRelatedToAcquisitionOfIntellectualProperty
3157000
CY2018 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
84000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
630000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
876000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1597000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1392000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1022000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3749000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
19000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35534000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10985000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
362000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7500000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
107854000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100716000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
90908000
CY2018 torc Proceeds From Payment For Deferred Offering Costs
ProceedsFromPaymentForDeferredOfferingCosts
-970000
CY2017 torc Proceeds From Payment For Deferred Offering Costs
ProceedsFromPaymentForDeferredOfferingCosts
-568000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
89943000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64378000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-46307000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
53349000
CY2018 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
81620000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.5%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and marketable securities. The Company&#8217;s cash, cash equivalents and marketable securities are held by financial institutions in the United States. Amounts on deposit may at times exceed federally insured limits. Management believes that the financial institution is financially sound, and accordingly, minimal credit risk exists with respect to the financial institution.</p>
CY2018 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2016-07-05
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1007000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
269000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
514000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
176000
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
900000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 torc Dividend Yield
DividendYield
0
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
101027000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
41000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
101027000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
100986000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
406000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
44000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5000
CY2018 us-gaap Depreciation
Depreciation
80000
CY2017 us-gaap Depreciation
Depreciation
5000
us-gaap Depreciation
Depreciation
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1189000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
394000
CY2018Q4 torc Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
1028000
CY2017Q4 torc Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
3250000
CY2017Q4 torc Deferred Offering Costs Current
DeferredOfferingCostsCurrent
238000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
510000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000
CY2017Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
20320667
CY2017 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2018 torc Fair Value Of Tranche Rights Liabilities Or Assets From Issuance Date
FairValueOfTrancheRightsLiabilitiesOrAssetsFromIssuanceDate
2017-03-23
CY2018 torc Fair Value Of Tranche Rights Liabilities Or Assets From Settlement Date
FairValueOfTrancheRightsLiabilitiesOrAssetsFromSettlementDate
2017-11-29
CY2018 torc Number Of Votes Entitled For Each Share Of Common Stock
NumberOfVotesEntitledForEachShareOfCommonStock
1
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2018 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
0
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2773249
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17736568
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7899000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-11484000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2340000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1011000
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
817000
CY2017 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
222000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
764000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
140000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
2202000
CY2018 torc Income Tax Reconciliation Change In Fair Value Of Tranche Rights
IncomeTaxReconciliationChangeInFairValueOfTrancheRights
3000
CY2017 torc Income Tax Reconciliation Change In Fair Value Of Tranche Rights
IncomeTaxReconciliationChangeInFairValueOfTrancheRights
5065000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
241000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10074000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5310000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 torc Percentage Of Net Operating Loss Carryforwards
PercentageOfNetOperatingLossCarryforwards
0.80
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
51000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
16000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15495000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5310000
CY2018Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
11000
CY2017Q4 torc Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
0
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13054000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3953000
CY2018Q4 torc Deferred Tax Assets Capitalized License
DeferredTaxAssetsCapitalizedLicense
869000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15373000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5310000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
122000
CY2018Q4 torc Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
111000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
122000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Litigation Reserve
LitigationReserve
0
CY2018 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2018-01-01
CY2018 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-02-28
CY2018 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2017 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
231000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
236000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
39000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
506000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
10200000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
14113000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
9032000
CY2018Q4 us-gaap Costs And Expenses
CostsAndExpenses
6360000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
39705000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10200000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14113000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9032000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6360000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-9859000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-13591000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-8407000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-5757000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9859000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13591000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8407000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5757000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37614000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
3357000
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
4057000
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
3945000
CY2017Q4 us-gaap Costs And Expenses
CostsAndExpenses
7523000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
18882000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3357000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4057000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3945000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7523000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3357000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-4057000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3310000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-23054000
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3357000
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4057000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33778000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.11
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3310000
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23054000

Files In Submission

Name View Source Status
0001564590-19-008262-index-headers.html Edgar Link pending
0001564590-19-008262-index.html Edgar Link pending
0001564590-19-008262.txt Edgar Link pending
0001564590-19-008262-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gjfl1beldm0d000001.jpg Edgar Link pending
gjfl1beldm0d000002.jpg Edgar Link pending
gjfl1beldm0d000003.jpg Edgar Link pending
gjfl1beldm0d000004.jpg Edgar Link pending
gjfl1beldm0d000005.jpg Edgar Link pending
gjfl1beldm0d000006.jpg Edgar Link pending
gjfl1beldm0d000007.jpg Edgar Link pending
gjfl1beldm0d000008.jpg Edgar Link pending
gjfl1beldm0d000009.jpg Edgar Link pending
gjfl1beldm0d000010.jpg Edgar Link pending
gjfl1beldm0d000011.jpg Edgar Link pending
gjfl1beldm0d000012.jpg Edgar Link pending
gjfl1beldm0d000013.jpg Edgar Link pending
gjfl1beldm0d000014.jpg Edgar Link pending
gjfl1beldm0d000015.jpg Edgar Link pending
gjfl1beldm0d000016.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
torc-10k_20181231.htm Edgar Link pending
torc-20181231.xml Edgar Link completed
torc-20181231.xsd Edgar Link pending
torc-20181231_cal.xml Edgar Link unprocessable
torc-20181231_def.xml Edgar Link unprocessable
torc-20181231_lab.xml Edgar Link unprocessable
torc-20181231_pre.xml Edgar Link unprocessable
torc-ex211_29.htm Edgar Link pending
torc-ex231_28.htm Edgar Link pending
torc-ex311_31.htm Edgar Link pending
torc-ex312_30.htm Edgar Link pending
torc-ex321_32.htm Edgar Link pending